Commission Implementing Decision of 30 November 2012 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2013 (notified under document C(2012) 8682) (2012/761/EU)

CHAPTER I ANNUAL PROGRAMMES

Article 1 Bovine brucellosis

1. The programmes for the eradication of bovine brucellosis submitted by Spain, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.

The programme for the eradication of bovine brucellosis submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 0,2 per rose bengal test;

(iii)

EUR 0,2 per SAT test;

(iv)

EUR 0,4 per complement fixation test;

(v)

EUR 0,5 per ELISA test;

(vi)

EUR 10 per bacteriological test;

(vii)

EUR 1 per domestic animal vaccinated;

(b) shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 375 per animal slaughtered;

(c) and shall not exceed the following:

(i)

EUR 4 000 000 for Spain;

(ii)

EUR 100 000 for Croatia;

(iii)

EUR 1 200 000 for Italy;

(iv)

EUR 1 000 000 for Portugal;

(v)

EUR 1 100 000 for the United Kingdom.

Article 2 Bovine tuberculosis

1. The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.

The programme for the eradication of bovine tuberculosis submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 1,5 per tuberculin test;

(iii)

EUR 5 per gamma-interferon test;

(iv)

EUR 10 per bacteriological test;

(b) shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 375 per animal slaughtered;

(c) and shall not exceed the following:

(i)

EUR 19 000 000 for Ireland;

(ii)

EUR 14 000 000 for Spain;

(iii)

EUR 400 000 for Croatia;

(iv)

EUR 3 300 000 for Italy;

(v)

EUR 2 600 000 for Portugal;

(vi)

EUR 31 800 000 for the United Kingdom.

Article 3 Ovine and caprine brucellosis

1. The programmes for the eradication of ovine and caprine brucellosis submitted by Greece, Italy, Spain, Cyprus, and Portugal are hereby approved for the period from 1 January to 31 December 2013.

2. The financial contribution by the Union, except for Greece:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 0,2 per rose bengal test;

(iii)

EUR 0,4 per complement fixation test;

(iv)

EUR 10 per bacteriological test;

(v)

EUR 1 per domestic animal vaccinated;

(b) shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 50 per animal slaughtered; and

(c) shall not exceed the following:

(i)

EUR 7 500 000 for Spain;

(ii)

EUR 3 500 000 for Italy;

(iii)

EUR 180 000 for Cyprus;

(iv)

EUR 2 000 000 for Portugal.

3. The financial contribution by the Union for Greece:

(a) shall be at the rate of 50 % of the costs to be incurred for:

(i)

the purchase of vaccines;

(ii)

the cost of carrying out laboratory tests;

(iii)

the salaries of contractual staff specially recruited for the implementation of the measures of that programme, other than to carry out laboratory tests;

(iv)

the compensation to be paid to owners for the value of its animals slaughtered subject to that programme; and

(b) shall not exceed EUR 4 000 000.

4. The maximum of the costs to be reimbursed to Greece for the programme referred to in paragraph 1 shall on average not exceed:

(i)

EUR 0,2 per rose bengal test;

(ii)

EUR 0,4 per complement fixation test;

(iii)

EUR 10 per bacteriological test;

(iv)

EUR 1 per dose for the purchase of vaccine;

(v)

EUR 50 per animal slaughtered.

Article 4 Bluetongue in endemic or high-risk areas

1. The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Germany, Ireland, Greece, Spain, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia and Finland are hereby approved for the period from 1 January to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 1 per domestic animal vaccinated;

(iii)

EUR 2 per ELISA test;

(iv)

EUR 10 per PCR test;

(v)

EUR 10 per virological test;

(b) shall not exceed the following:

(i)

EUR 25 000 for Belgium;

(ii)

EUR 11 000 for Bulgaria;

(iii)

EUR 10 000 for the Czech Republic;

(iv)

EUR 100 000 for Germany;

(v)

EUR 10 000 for Ireland;

(vi)

EUR 100 000 for Greece;

(vii)

EUR 40 000 for Spain;

(viii)

EUR 650 000 for Italy;

(ix)

EUR 10 000 for Latvia;

(x)

EUR 10 000 for Lithuania;

(xi)

EUR 10 000 for Luxembourg;

(xii)

EUR 10 000 for Hungary;

(xiii)

EUR 10 000 for Malta;

(xiv)

EUR 10 000 for the Netherlands;

(xv)

EUR 10 000 for Austria;

(xvi)

EUR 50 000 for Poland;

(xvii)

EUR 300 000 for Portugal;

(xviii)

EUR 140 000 for Romania;

(xix)

EUR 25 000 for Slovenia;

(xx)

EUR 40 000 for Slovakia;

(xxi)

EUR 10 000 for Finland.

Article 5 Salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo)

1. The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.

The programme for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per official sample taken;

(ii)

EUR 7 per test for a bacteriological test (cultivation/isolation);

(iii)

EUR 15 per for test for serotyping of relevant isolates of salmonella spp.;

(iv)

EUR 5 per test for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock;

(v)

EUR 3 per test for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella;

(vi)

EUR 0,02 per dose for the purchase of vaccine doses;

(b) shall be at the rate of 50 % of the costs to be incurred by each Member State for the compensation to be paid to owners for the value of:

• (b) the culled breeding and laying birds of Gallus gallus,

• the culled breeding turkey birds of Meleagris gallopavo,

• the destroyed eggs as referred to in paragraph (d);

(c) and shall not exceed the following:

(i)

EUR 1 000 000 for Belgium;

(ii)

EUR 25 000 for Bulgaria;

(iii)

EUR 1 400 000 for the Czech Republic;

(iv)

EUR 150 000 for Denmark;

(v)

EUR 900 000 for Germany;

(vi)

EUR 25 000 for Estonia;

(vii)

EUR 480 000 for Ireland;

(viii)

EUR 500 000 for Greece;

(ix)

EUR 1 200 000 for Spain;

(x)

EUR 1 250 000 for France;

(xi)

EUR 200 000 for Croatia;

(xii)

EUR 1 000 000 for Italy;

(xiii)

EUR 60 000 for Cyprus;

(xiv)

EUR 290 000 for Latvia;

(xv)

EUR 25 000 for Luxembourg;

(xvi)

EUR 950 000 for Hungary;

(xvii)

EUR 50 000 for Malta;

(xviii)

EUR 2 400 000 for the Netherlands;

(xix)

EUR 700 000 for Austria;

(xx)

EUR 2 700 000 for Poland;

(xxi)

EUR 25 000 for Portugal;

(xxii)

EUR 620 000 for Romania;

(xxiii)

EUR 60 000 for Slovenia;

(xxiv)

EUR 450 000 for Slovakia;

(xxv)

EUR 60 000 for the United Kingdom;

(d) the maximum of the cost to be reimbursed to the Member States for the program referred to in paragraph 1 shall on average not exceed:

(i) a parent breeding bird of Gallus gallus culled

:

EUR 4 per bird;

(ii) a commercial laying bird of Gallus gallus culled

:

EUR 2,20 per bird;

(iii) a parent breeding turkey bird of Meleagris gallopavo culled

:

EUR 12 per bird;

(iv) hatching eggs of parent breeding Gallus gallus

:

EUR 0,20 per hatching egg destroyed;

(v) table eggs of Gallus gallus

:

EUR 0,04 per table egg destroyed;

(vi) hatching eggs of parent breeding Meleagris gallopavo

:

EUR 0,40 per hatching egg destroyed.

Article 6 Classical swine fever

1. The programmes for the control and monitoring of Classical swine fever submitted by Bulgaria, Germany, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January to 31 December 2013.

The programme for the control and monitoring of Classical swine fever submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

(ii)

EUR 5 per wild boar sampled;

(iii)

EUR 1 per bait/vaccine;

(iv)

EUR 2 per ELISA test;

(v)

EUR 10 per PCR test;

(vi)

EUR 10 per virological test;

(b) shall not exceed the following:

(i)

EUR 200 000 for Bulgaria;

(ii)

EUR 810 000 for Germany;

(iii)

EUR 100 000 for Croatia;

(iv)

EUR 50 000 for Hungary;

(v)

EUR 1 000 000 for Romania;

(vi)

EUR 25 000 for Slovenia;

(vii)

EUR 400 000 for Slovakia.

Article 7 African swine fever

1. The programme for the control and monitoring of African swine fever submitted by Italy is hereby approved for the period from 1 January to 31 December 2013.

2. The financial contribution by the Union:

(a) shall be at the rate of 50 % of the costs to be incurred by Italy for:

(i)

the cost of carrying out laboratory tests;

(ii)

the salaries of contractual staff specially recruited for the implementation of the measures of that programme, other than to carry out laboratory tests;

(b) shall not exceed EUR 1 400 000.

3. The maximum of the costs to be reimbursed to Italy shall on average not exceed:

(i)

EUR 2 per ELISA test;

(ii)

EUR 10 per PCR test;

(iii)

EUR 10 per virological test.

Article 8 Swine vesicular disease

1. The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

(ii)

EUR 2 per ELISA test;

(iii)

EUR 4 per seroneutralisation test;

(iv)

EUR 10 per PCR test;

(v)

EUR 10 per virological test;

(b) shall not exceed EUR 900 000.

Article 9 Avian influenza in poultry and wild birds

1. The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.

The survey programme for avian influenza submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per sample from poultry flocks;

(ii)

EUR 5 per wild bird sampled in the framework of the passive surveillance;

(iii)

EUR 1 per ELISA test;

(iv)

EUR 1 per agar gel immune diffusion test;

(b) shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests other than those foreseen in point (a); and

(c) shall not exceed the following:

(i)

EUR 30 000 for Belgium;

(ii)

EUR 25 000 for Bulgaria;

(iii)

EUR 25 000 for the Czech Republic;

(iv)

EUR 50 000 for Denmark;

(v)

EUR 50 000 for Germany;

(vi)

EUR 70 000 for Ireland;

(vii)

EUR 25 000 for Greece;

(viii)

EUR 90 000 for Spain;

(ix)

EUR 120 000 for France;

(x)

EUR 40 000 for Croatia;

(xi)

EUR 1 000 000 for Italy;

(xii)

EUR 25 000 for Cyprus;

(xiii)

EUR 25 000 for Latvia;

(xiv)

EUR 25 000 for Lithuania;

(xv)

EUR 25 000 for Luxembourg;

(xvi)

EUR 130 000 for Hungary;

(xvii)

EUR 25 000 for Malta;

(xviii)

EUR 170 000 for the Netherlands;

(xix)

EUR 30 000 for Austria;

(xx)

EUR 100 000 for Poland;

(xxi)

EUR 25 000 for Portugal;

(xxii)

EUR 350 000 for Romania;

(xxiii)

EUR 35 000 for Slovenia;

(xxiv)

EUR 25 000 for Slovakia;

(xxv)

EUR 25 000 for Finland;

(xxvi)

EUR 30 000 for Sweden;

(xxvii)

EUR 110 000 for the United Kingdom.

3. The maximum of the costs to be reimbursed to the Member States for the tests covered by the programmes shall on average not exceed:

(a) HI test for H5/H7

:

EUR 12 per test;

(b) virus isolation test

:

EUR 40 per test;

(c) PCR test

:

EUR 20 per test.

Article 10 Transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie

1. The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2013.

The programme for the monitoring of transmissible spongiform encephalopathies (TSE) and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Croatia is hereby approved for the period from 1 July to 31 December 2013.

2. The financial contribution by the Union:

(a) shall consist of a lump sum of:

(i)

EUR 8,5 per test, compensating for all costs incurred to perform rapid tests, to fulfil the requirements of Article 12(2) and Chapter A, Part I, of Annex III to Regulation (EC) No 999/2001 or used as confirmatory tests in accordance with Chapter C of Annex X to the same Regulation;

(ii)

EUR 15 per test, compensating for all costs incurred to perform rapid tests to fulfil the requirements of Article 12(2), Chapter A, Part II, points 1 to 5, of Annex III, and Annex VII to Regulation (EC) No 999/2001;

(iii)

EUR 4 per test, compensating for all costs incurred to perform genotyping tests;

(iv)

EUR 120 per test, compensating for all costs incurred to perform primary molecular discriminatory tests as referred to in Chapter C, point 3(2)(c)(i), of Annex X to Regulation (EC) No 999/2001; and

(v)

EUR 25 per test, compensating for all costs incurred to perform confirmatory tests, other than rapid tests, as referred to in Chapter C of Annex X to Regulation (EC) No 999/2001;

(b) shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to be paid to owners for the value of their animals:

(i)

culled and destroyed in accordance with their BSE and scrapie eradication programmes;

(ii)

compulsorily slaughtered in accordance with Chapter A, point 2.3(d), of Annex VII to Regulation (EC) No 999/2001;

(c) shall not exceed the following:

(i)

EUR 1 270 000 for Belgium;

(ii)

EUR 270 000 for Bulgaria;

(iii)

EUR 580 000 for the Czech Republic;

(iv)

EUR 730 000 for Denmark;

(v)

EUR 6 260 000 for Germany;

(vi)

EUR 100 000 for Estonia;

(vii)

EUR 2 900 000 for Ireland;

(viii)

EUR 1 700 000 for Greece;

(ix)

EUR 4 300 000 for Spain;

(x)

EUR 12 600 000 for France;

(xi)

EUR 4 800 000 for Italy;

(xii)

EUR 230 000 for Croatia;

(xiii)

EUR 1 900 000 for Cyprus;

(xiv)

EUR 220 000 for Latvia;

(xv)

EUR 420 000 for Lithuania;

(xvi)

EUR 80 000 for Luxembourg;

(xvii)

EUR 850 000 for Hungary;

(xviii)

EUR 25 000 for Malta;

(xix)

EUR 2 200 000 for the Netherlands;

(xx)

EUR 1 080 000 for Austria;

(xxi)

EUR 2 600 000 for Poland;

(xxii)

EUR 1 100 000 for Portugal;

(xxiii)

EUR 1 200 000 for Romania;

(xxiv)

EUR 200 000 for Slovenia;

(xxv)

EUR 250 000 for Slovakia;

(xxvi)

EUR 370 000 for Finland;

(xxvii)

EUR 500 000 for Sweden;

(xxviii)

EUR 5 100 000 for the United Kingdom.

3. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for culled and destroyed bovine animals

:

EUR 500 per animal;

(b) for culled and destroyed sheep or goats

:

EUR 70 per animal;

(c) for slaughtered sheep and goats

:

EUR 50 per animal.

Article 11 Rabies

1. The programmes for the eradication of rabies submitted by Bulgaria, Greece, Estonia, Italy, Lithuania, Hungary, Poland, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January to 31 December 2013.

2. The financial contribution by the Union:

(a) shall include a lump sum of EUR 5 per wild animal sampled;

(b) shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of:

(i)

carrying out laboratory tests for the detection of rabies antigen or antibodies;

(ii)

the isolation and characterisation of rabies virus;

(iii)

the detection of biomarker and the titration of vaccine baits;

(iv)

the purchase and distribution of oral vaccine plus baits;

(v)

the purchase and administration of parenteral vaccines to grazing animals;

(c) shall be at the rate of 75 % of the costs to be incurred by Greece for the salaries of contractual staff specially recruited for laboratory work under that programme; and

(d) shall not exceed the following:

(i)

EUR 1 540 000 for Bulgaria;

(ii)

EUR 1 000 000 for Greece;

(iii)

EUR 620 000 for Estonia;

(iv)

EUR 200 000 for Italy;

(v)

EUR 3 150 000 for Lithuania;

(vi)

EUR 1 620 000 for Hungary;

(vii)

EUR 6 560 000 for Poland;

(viii)

EUR 6 000 000 for Romania;

(ix)

EUR 800 000 for Slovenia;

(x)

EUR 400 000 for Slovakia.

3. The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a) for a serological test

:

EUR 12 per test;

(b) for a test to detect tetracycline in bone

:

EUR 12 per test;

(c) for a fluorescent antibody test (FAT)

:

EUR 18 per test;

(d) for the purchase of oral vaccine plus baits

:

EUR 0,60 per dose;

(e) for the distribution of oral vaccine plus baits

:

EUR 0,35 per dose.

4. Notwithstanding paragraph 2 points (a) and (b) and paragraph 3, for the part of the Lithuanian and Polish programmes that will be implemented outside these Member States’ territories, the financial contribution by the Union shall:

(a) be granted only for the costs of the purchase and of the distribution of oral vaccine plus baits;

(b) be at the rate of 100 %; and

(c) not exceed:

(i)

EUR 1 260 000 for Lithuania;

(ii)

EUR 1 260 000 for Poland.

5. The maximum of the costs to be reimbursed for the costs referred to in paragraph 4 shall on average not exceed for the purchase and the distribution of oral vaccine plus baits EUR 0,95 per dose.